A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to notifications of emerging signals concerning devices.
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 6, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 6, 2022
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
This bill establishes certain requirements relating to the Food and Drug Administration's (FDA's) public notices on the potential new risks of approved medical devices (i.e., emerging signals), including with respect to the standards of evidence needed for such notices. The FDA must update its current guidance on emerging signals to align with the bill's requirements.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related & companion bills
1
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 4349: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to notifications of emerging signals concerning devices.. 117th Congress. Open America. https://openamerica.io/bill/117-S-4349/
"S. 4349: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to notifications of emerging signals concerning devices.." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4349/.
S. 4349, 117th Cong. (2026), https://openamerica.io/bill/117-S-4349/.
[S. 4349: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to notifications of emerging signals concerning devices.](https://openamerica.io/bill/117-S-4349/)